SCHEMBL11894589

SCHEMBL11894589

COC(=O)Cc1c(C)c2ccc(N)cc2oc1=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 14/20 0.69
MAPT P10636 5/20 0.69
RAB9A P51151 4/20 0.69
NPC1 O15118 3/20 0.69
ALDH1A1 P00352 11/20 0.66
HPGD P15428 10/20 0.66
HSD17B10 Q99714 10/20 0.66
SMN1; SMN2 Q16637 3/20 0.66
TSHR P16473 2/20 0.66
GAA P10253 5/20 0.62
KMT2A Q03164 5/20 0.62
GLA P06280 4/20 0.62
CA12 O43570 4/20 0.60
CA9 Q16790 4/20 0.60
CASP1 P29466 4/20 0.60
CASP7 P55210 4/20 0.60
MAPK1 P28482 2/20 0.60
SRC P12931 1/20 0.60
ATM Q13315 2/20 0.56
NPSR1 Q6W5P4 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10650322 0.86 KDM4E (0.70) KDM4EMAPTRAB9ANPC1ALDH1A1
SCHEMBL3994327 0.85 SRC (0.64) KDM4EMAPTRAB9ANPC1ALDH1A1
SCHEMBL29752815 0.85 SRC (0.64) KDM4EMAPTRAB9ANPC1ALDH1A1
SCHEMBL72225 0.85 SRC (0.64) KDM4EMAPTRAB9ANPC1ALDH1A1
SCHEMBL13840542 0.85 SRC (0.64) KDM4EMAPTRAB9ANPC1ALDH1A1
SCHEMBL7110939 0.85 SRC (0.60) KDM4EMAPTRAB9ANPC1ALDH1A1
SCHEMBL10349724 0.84 SRC (0.62) KDM4EMAPTRAB9ANPC1ALDH1A1
SCHEMBL2528490 0.83 SRC (0.53) KDM4EMAPTRAB9ANPC1ALDH1A1
SCHEMBL29577443 0.83 SRC (0.53) KDM4EMAPTRAB9ANPC1ALDH1A1
SCHEMBL24807336 0.83 SRC (0.64) KDM4EMAPTRAB9ANPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8709721-B2 Fluorescent molecule and method for detecting target nucleic acid RIKEN (JP) 2014-04-29 US disclosed
EP-2484671-A1 FLUORESCENT MOLECULE AND METHOD FOR DETECTING TARGET NUCLEIC ACID Riken (JP) 2012-08-08 EP disclosed
EP-2484671-A1 FLUORESCENT MOLECULE AND METHOD FOR DETECTING TARGET NUCLEIC ACID Riken (JP) 2012-08-08 EP disclosed
US-20120196377-A1 FLUORESCENT MOLECULE AND METHOD FOR DETECTING TARGET NUCLEIC ACID RIKEN (JP) 2012-08-02 US disclosed
US-20120196377-A1 FLUORESCENT MOLECULE AND METHOD FOR DETECTING TARGET NUCLEIC ACID RIKEN (JP) 2012-08-02 US disclosed
US-20120196377-A1 FLUORESCENT MOLECULE AND METHOD FOR DETECTING TARGET NUCLEIC ACID RIKEN (JP) 2012-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120196377-A1 FLUORESCENT MOLECULE AND METHOD FOR DETECTING TARGET NUCLEIC ACID DNTT, POLL, POLRMT KDM4E 3822/4885MAPT 4731/4885RAB9A 3549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.